|Bid||394.34 x 800|
|Ask||394.67 x 800|
|Day's range||391.57 - 399.27|
|52-week range||188.22 - 428.22|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||37.32|
|Earnings date||25 Oct 2021 - 29 Oct 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||26 Nov 1996|
|1y target est||361.75|
How far off is Waters Corporation ( NYSE:WAT ) from its intrinsic value? Using the most recent financial data, we'll...
MILFORD, Mass., September 16, 2021--The BioAccord System with ACQUITY Premier simplifies CQA monitoring of biologics by improving analyte recovery and assay-to-assay reproducibility.
Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.